perfect synopsis of where we are - thanks for writing this. it's a balanced assessment of things and how we arrived here - some forced errors and some unforced - which is pretty much life. But the unforced errors seem to be leading to better decisions going forward - and that's the key as i see it.

NP and Kelly (in my opinion at least) are hard working, smart and are aligned with us in terms of wanting to maximize the value of this drug, and get it out to people in need. At the current moment - there isn't another option that meets those criteria (certainly not in 13D). I'm excited about Q4 of this year - and trying to ease off on watching the ticker until then